Alpha Tau Medical Ltd ($DRTS) announced an update on their ongoing clinical study. Study Overview – Alpha Tau Medical Ltd. (NASDAQ: DRTS) is ...

King Charles shared his cancer diagnosis in February 2024 after undergoing a procedure for an enlarged prostate and has received treatment that will be 'reduced' in 2026. Here's everything to know ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Background: In the last decade, several studies have proven the effectiveness of low-intensity shock waves (LI-ESWT), but with several factors that make it difficult to carry out systematic reviews.

A groundbreaking trial for a prostate cancer treatment has been launched in the UK, with the hope of reducing the side ...

Vincent Giguère, Professor in McGill’s Department of Biochemistry and researcher at the Rosalind and Morris Goodman Cancer Institute. (Source: Owen Egan and Joni Dufour) Researchers find mechanism ...

The final, formatted version of the article will be published soon. Background: The incidence of macrolide-resistant Mycoplasma pneumoniae pneumonia (MRMPP) has been increasing in children, resulting ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...